QSAR Modeling and Biological Testing of Some 15-LOX Inhibitors in a Series of Homo- and Heterocyclic Compounds

This paper examines the quantitative structure–inhibitory activity relationship of 15-lipoxygenase (15-LOX) in sets of 100 homo- and heterocyclic compounds using GUSAR 2019 software. Statistically significant valid models were built to predict the IC50 parameter. A combination of MNA and QNA descrip...

Full description

Saved in:
Bibliographic Details
Main Authors: Veronika Khairullina, Yuliya Martynova, Matvey Kanevsky, Irina Kanevskaya, Yurii Zimin, Leonid Maksimov
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/29/23/5540
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846124061914038272
author Veronika Khairullina
Yuliya Martynova
Matvey Kanevsky
Irina Kanevskaya
Yurii Zimin
Leonid Maksimov
author_facet Veronika Khairullina
Yuliya Martynova
Matvey Kanevsky
Irina Kanevskaya
Yurii Zimin
Leonid Maksimov
author_sort Veronika Khairullina
collection DOAJ
description This paper examines the quantitative structure–inhibitory activity relationship of 15-lipoxygenase (15-LOX) in sets of 100 homo- and heterocyclic compounds using GUSAR 2019 software. Statistically significant valid models were built to predict the IC50 parameter. A combination of MNA and QNA descriptors with three whole molecular descriptors (topological length, topological volume and lipophilicity) was used to develop 18 statistically significant, valid consensus QSAR models. These compounds showed varying degrees of inhibition of the catalytic activity of 15-LOX: the range of variation in the pIC<sub>50</sub> value was 3.873. The satisfactory coincidence between the theoretically calculated and experimentally determined pIC<sub>50</sub> values for compounds TS1, TS2 and <b>1–8</b> suggests the potential use of models M1–M18 for the virtual screening of virtual libraries and databases to find new potentially efficient inhibitors of 15-LOX.
format Article
id doaj-art-5a6d0bf09cb94b51b79f809a554c906f
institution Kabale University
issn 1420-3049
language English
publishDate 2024-11-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj-art-5a6d0bf09cb94b51b79f809a554c906f2024-12-13T16:28:13ZengMDPI AGMolecules1420-30492024-11-012923554010.3390/molecules29235540QSAR Modeling and Biological Testing of Some 15-LOX Inhibitors in a Series of Homo- and Heterocyclic CompoundsVeronika Khairullina0Yuliya Martynova1Matvey Kanevsky2Irina Kanevskaya3Yurii Zimin4Leonid Maksimov5Institute of Chemistry and Protection in Emergency Situations, Ufa University of Science and Technology, 50076 Ufa, RussiaInstitute of Chemistry and Protection in Emergency Situations, Ufa University of Science and Technology, 50076 Ufa, RussiaFaculty of Biology, Saratov State University, 410012 Saratov, RussiaInstitute of Chemistry, Saratov State University, 410012 Saratov, RussiaInstitute of Chemistry and Protection in Emergency Situations, Ufa University of Science and Technology, 50076 Ufa, RussiaInstitute of Chemistry and Protection in Emergency Situations, Ufa University of Science and Technology, 50076 Ufa, RussiaThis paper examines the quantitative structure–inhibitory activity relationship of 15-lipoxygenase (15-LOX) in sets of 100 homo- and heterocyclic compounds using GUSAR 2019 software. Statistically significant valid models were built to predict the IC50 parameter. A combination of MNA and QNA descriptors with three whole molecular descriptors (topological length, topological volume and lipophilicity) was used to develop 18 statistically significant, valid consensus QSAR models. These compounds showed varying degrees of inhibition of the catalytic activity of 15-LOX: the range of variation in the pIC<sub>50</sub> value was 3.873. The satisfactory coincidence between the theoretically calculated and experimentally determined pIC<sub>50</sub> values for compounds TS1, TS2 and <b>1–8</b> suggests the potential use of models M1–M18 for the virtual screening of virtual libraries and databases to find new potentially efficient inhibitors of 15-LOX.https://www.mdpi.com/1420-3049/29/23/5540inhibitors of 15-lipoxygenase15-LOXQSAR modelsGUSAR 2019 programQNA descriptorsMNA descriptors
spellingShingle Veronika Khairullina
Yuliya Martynova
Matvey Kanevsky
Irina Kanevskaya
Yurii Zimin
Leonid Maksimov
QSAR Modeling and Biological Testing of Some 15-LOX Inhibitors in a Series of Homo- and Heterocyclic Compounds
Molecules
inhibitors of 15-lipoxygenase
15-LOX
QSAR models
GUSAR 2019 program
QNA descriptors
MNA descriptors
title QSAR Modeling and Biological Testing of Some 15-LOX Inhibitors in a Series of Homo- and Heterocyclic Compounds
title_full QSAR Modeling and Biological Testing of Some 15-LOX Inhibitors in a Series of Homo- and Heterocyclic Compounds
title_fullStr QSAR Modeling and Biological Testing of Some 15-LOX Inhibitors in a Series of Homo- and Heterocyclic Compounds
title_full_unstemmed QSAR Modeling and Biological Testing of Some 15-LOX Inhibitors in a Series of Homo- and Heterocyclic Compounds
title_short QSAR Modeling and Biological Testing of Some 15-LOX Inhibitors in a Series of Homo- and Heterocyclic Compounds
title_sort qsar modeling and biological testing of some 15 lox inhibitors in a series of homo and heterocyclic compounds
topic inhibitors of 15-lipoxygenase
15-LOX
QSAR models
GUSAR 2019 program
QNA descriptors
MNA descriptors
url https://www.mdpi.com/1420-3049/29/23/5540
work_keys_str_mv AT veronikakhairullina qsarmodelingandbiologicaltestingofsome15loxinhibitorsinaseriesofhomoandheterocycliccompounds
AT yuliyamartynova qsarmodelingandbiologicaltestingofsome15loxinhibitorsinaseriesofhomoandheterocycliccompounds
AT matveykanevsky qsarmodelingandbiologicaltestingofsome15loxinhibitorsinaseriesofhomoandheterocycliccompounds
AT irinakanevskaya qsarmodelingandbiologicaltestingofsome15loxinhibitorsinaseriesofhomoandheterocycliccompounds
AT yuriizimin qsarmodelingandbiologicaltestingofsome15loxinhibitorsinaseriesofhomoandheterocycliccompounds
AT leonidmaksimov qsarmodelingandbiologicaltestingofsome15loxinhibitorsinaseriesofhomoandheterocycliccompounds